In a report released Monday afternoon, federal inspectors detailed 15 problems found at major hospital drug supplier Ameridose LLC, ranging from insufficient testing of the sterility and potency of the drugs it made to the presence of vermin in an area where sterile products were packaged and stored.

Inspectors also wrote that the company did not adequately investigate instances when solutions used to manufacture drugs were determined to be potentially contaminated with microbes, the report said.